Efficacy and safety of subthreshold micropulse laser for chronic central serous chorioretinopathy: a systematic review and meta-analysis
Authors:
Open Access
- 13 March 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1785787
Abstract
Background: Chronic central serous chorioretinopathy (cCSC) can lead to irreversible visual impairment. Traditional treatment methods are limited by their efficacy and the risk of complications. Subthreshold micropulse laser (SML) therapy has emerged as a promising treatment option. Objective: This study systematically evaluated the efficacy and safety of SML for treating cCSC, providing evidence-based clinical recommendations. Methods: We searched PubMed, Embase, Cochrane Library, and Web of Science for studies published up to January 10, 2025, evaluating SML for cCSC. Eligible designs included randomized controlled trials (RCTs), prospective cohort studies, and case series. Two researchers independently performed literature screening, data extraction, and quality assessment using RoB 2, NOS, and JBI tools, respectively. The certainty of evidence was evaluated using the GRADE system. Meta-analysis was conducted using STATA 18.0 to pool the effects on visual acuity (BCVA) and retinal morphology (CMT, CT, CRT). Subgroup analyses were performed based on laser wavelengths (527, 532, 577, and 810 nm). Results: A total of 1,412 articles were identified, and 21 studies were included, with a total sample size of 939 eyes. Meta-analysis demonstrated that SML significantly improved the best-corrected visual acuity (BCVA) of cCSC patients, with a pooled effect size of [SMD = −0.74, 95% CI (−1.14, −0.33), P = 0.001]. The efficacy was consistent across different wavelengths (527, 532, 577, 810 nm). Regarding retinal morphological parameters, SML significantly reduced the central macular thickness [CMT, SMD = −2.15; 95% CI (−3.82, −0.47), P = 0.018], choroidal thickness [CT, SMD = −0.43; 95% CI (−0.79, −0.08), P = 0.025], and central retinal thickness [CRT, SMD = −1.12; 95% CI (−1.34, −0.90), P = 0.001]. Although improvements in subretinal fluid height (SRFH) were not statistical significance, most studies indicated a positive trend. Additionally, SML demonstrated a high safety profile for treating cCSC. Conclusion: SML significantly improves visual function and retinal morphology in cCSC patients, demonstrating consistent efficacy across different wavelengths and providing a safe, effective treatment option for cCSC.Keywords
This publication has 39 references indexed in Scilit:
- Evaluation of changes in macular structures after subthreshold micropulse laser therapy on chronic central serous chorioretinopathyLasers in Medical Science, 2024
- Subthreshold micropulse diode laser treatment in diabetic macular edema: biological impact, therapeutic effects, and safetyInternational Ophthalmology, 2024
- Yellow Subthreshold Micropulse Laser in Retinal Diseases: An In-Depth Analysis and Review of the LiteratureOphthalmology and Therapy, 2023
- 532 nm versus 810 nm subthreshold micropulse laser in treatment of non-resolving central serous chorioretinopathy: A randomized controlled trialMedical Journal Armed Forces India, 2023
- Electrophysiological and anatomical outcomes of subthreshold micropulse laser therapy in chronic central serous chorioretinopathyPhotodiagnosis and Photodynamic Therapy, 2022
- The efficacy of subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathyLasers in Medical Science, 2020
- Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous ChorioretinopathyOphthalmology, 2018
- Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laserGraefe's Archive for Clinical and Experimental Ophthalmology, 2017
- A Review of Subthreshold Micropulse Laser for Treatment of Macular DisordersAdvances in Therapy, 2017
- Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathyGraefe's Archive for Clinical and Experimental Ophthalmology, 2015